Emily Whitehead, then a 6-year-old with acute lymphoblastic leukemia, was treated with Kymriah (anti-CD19 CAR-T cells) in 2012 and has been free of the disease for 11 years, making her the first patient with leukemia to be cured by CAR-T therapy. The gene discussed is CD19; the disease is acute lymphoblastic leukemia.